img

Global Vaccine Adjuvants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaccine Adjuvants Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combinationthese are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Vaccine Adjuvants report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaccine Adjuvants market is projected to reach US$ 1569.9 million in 2034, increasing from US$ 852.8 million in 2022, with the CAGR of 9.0% during the period of 2024 to 2034. Demand from Human Vaccine and Veterinary Vaccine are the major drivers for the industry.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccine Adjuvants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Segment by Type
Aluminum Adjuvant
Emulsions Adjuvant
Others

Segment by Application


Human Vaccine
Veterinary Vaccine

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Vaccine Adjuvants market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vaccine Adjuvants, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vaccine Adjuvants industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vaccine Adjuvants in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vaccine Adjuvants introduction, etc. Vaccine Adjuvants Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Vaccine Adjuvants market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Product Overview
1.2 Vaccine Adjuvants Market Segment by Type
1.2.1 Aluminum Adjuvant
1.2.2 Emulsions Adjuvant
1.2.3 Others
1.3 Global Vaccine Adjuvants Market Size by Type
1.3.1 Global Vaccine Adjuvants Market Size Overview by Type (2018-2034)
1.3.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine Adjuvants Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vaccine Adjuvants Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2018-2024)
2 Global Vaccine Adjuvants Market Competition by Company
2.1 Global Top Players by Vaccine Adjuvants Sales (2018-2024)
2.2 Global Top Players by Vaccine Adjuvants Revenue (2018-2024)
2.3 Global Top Players by Vaccine Adjuvants Price (2018-2024)
2.4 Global Top Manufacturers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine Adjuvants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccine Adjuvants Market
2.8 Key Manufacturers Vaccine Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine Adjuvants Status and Outlook by Region
3.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Vaccine Adjuvants Historic Market Size by Region
3.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2018-2024)
3.2.2 Global Vaccine Adjuvants Sales in Value by Region (2018-2024)
3.2.3 Global Vaccine Adjuvants Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vaccine Adjuvants Forecasted Market Size by Region
3.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2024-2034)
3.3.2 Global Vaccine Adjuvants Sales in Value by Region (2024-2034)
3.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vaccine Adjuvants by Application
4.1 Vaccine Adjuvants Market Segment by Application
4.1.1 Human Vaccine
4.1.2 Veterinary Vaccine
4.2 Global Vaccine Adjuvants Market Size by Application
4.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2018-2034)
4.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vaccine Adjuvants Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2018-2024)
5 North America Vaccine Adjuvants by Country
5.1 North America Vaccine Adjuvants Historic Market Size by Country
5.1.1 North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Vaccine Adjuvants Sales in Volume by Country (2018-2024)
5.1.3 North America Vaccine Adjuvants Sales in Value by Country (2018-2024)
5.2 North America Vaccine Adjuvants Forecasted Market Size by Country
5.2.1 North America Vaccine Adjuvants Sales in Volume by Country (2024-2034)
5.2.2 North America Vaccine Adjuvants Sales in Value by Country (2024-2034)
6 Europe Vaccine Adjuvants by Country
6.1 Europe Vaccine Adjuvants Historic Market Size by Country
6.1.1 Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Vaccine Adjuvants Sales in Volume by Country (2018-2024)
6.1.3 Europe Vaccine Adjuvants Sales in Value by Country (2018-2024)
6.2 Europe Vaccine Adjuvants Forecasted Market Size by Country
6.2.1 Europe Vaccine Adjuvants Sales in Volume by Country (2024-2034)
6.2.2 Europe Vaccine Adjuvants Sales in Value by Country (2024-2034)
7 Asia-Pacific Vaccine Adjuvants by Region
7.1 Asia-Pacific Vaccine Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vaccine Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2024-2034)
8 Latin America Vaccine Adjuvants by Country
8.1 Latin America Vaccine Adjuvants Historic Market Size by Country
8.1.1 Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Vaccine Adjuvants Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vaccine Adjuvants Sales in Value by Country (2018-2024)
8.2 Latin America Vaccine Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Vaccine Adjuvants Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vaccine Adjuvants Sales in Value by Country (2024-2034)
9 Middle East and Africa Vaccine Adjuvants by Country
9.1 Middle East and Africa Vaccine Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vaccine Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Vaccine Adjuvants Products Offered
10.1.5 GSK Recent Development
10.2 CSL Limited
10.2.1 CSL Limited Company Information
10.2.2 CSL Limited Introduction and Business Overview
10.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Limited Vaccine Adjuvants Products Offered
10.2.5 CSL Limited Recent Development
10.3 Croda
10.3.1 Croda Company Information
10.3.2 Croda Introduction and Business Overview
10.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Croda Vaccine Adjuvants Products Offered
10.3.5 Croda Recent Development
10.4 SEPPIC
10.4.1 SEPPIC Company Information
10.4.2 SEPPIC Introduction and Business Overview
10.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.4.4 SEPPIC Vaccine Adjuvants Products Offered
10.4.5 SEPPIC Recent Development
10.5 Novavax
10.5.1 Novavax Company Information
10.5.2 Novavax Introduction and Business Overview
10.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novavax Vaccine Adjuvants Products Offered
10.5.5 Novavax Recent Development
10.6 SPI Pharma
10.6.1 SPI Pharma Company Information
10.6.2 SPI Pharma Introduction and Business Overview
10.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.6.4 SPI Pharma Vaccine Adjuvants Products Offered
10.6.5 SPI Pharma Recent Development
10.7 Phibro
10.7.1 Phibro Company Information
10.7.2 Phibro Introduction and Business Overview
10.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Phibro Vaccine Adjuvants Products Offered
10.7.5 Phibro Recent Development
10.8 SDA BIO
10.8.1 SDA BIO Company Information
10.8.2 SDA BIO Introduction and Business Overview
10.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.8.4 SDA BIO Vaccine Adjuvants Products Offered
10.8.5 SDA BIO Recent Development
10.9 Invivogen
10.9.1 Invivogen Company Information
10.9.2 Invivogen Introduction and Business Overview
10.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Invivogen Vaccine Adjuvants Products Offered
10.9.5 Invivogen Recent Development
10.10 Tj Kaiwei
10.10.1 Tj Kaiwei Company Information
10.10.2 Tj Kaiwei Introduction and Business Overview
10.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Tj Kaiwei Vaccine Adjuvants Products Offered
10.10.5 Tj Kaiwei Recent Development
10.11 OZ Biosciences
10.11.1 OZ Biosciences Company Information
10.11.2 OZ Biosciences Introduction and Business Overview
10.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.11.4 OZ Biosciences Vaccine Adjuvants Products Offered
10.11.5 OZ Biosciences Recent Development
10.12 Brenntag Biosector
10.12.1 Brenntag Biosector Company Information
10.12.2 Brenntag Biosector Introduction and Business Overview
10.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered
10.12.5 Brenntag Biosector Recent Development
10.13 MVP Laboratories
10.13.1 MVP Laboratories Company Information
10.13.2 MVP Laboratories Introduction and Business Overview
10.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.13.4 MVP Laboratories Vaccine Adjuvants Products Offered
10.13.5 MVP Laboratories Recent Development
10.14 Zhuoyue
10.14.1 Zhuoyue Company Information
10.14.2 Zhuoyue Introduction and Business Overview
10.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Zhuoyue Vaccine Adjuvants Products Offered
10.14.5 Zhuoyue Recent Development
10.15 Aphios
10.15.1 Aphios Company Information
10.15.2 Aphios Introduction and Business Overview
10.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Aphios Vaccine Adjuvants Products Offered
10.15.5 Aphios Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine Adjuvants Industrial Chain Analysis
11.4 Vaccine Adjuvants Market Dynamics
11.4.1 Vaccine Adjuvants Industry Trends
11.4.2 Vaccine Adjuvants Market Drivers
11.4.3 Vaccine Adjuvants Market Challenges
11.4.4 Vaccine Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine Adjuvants Distributors
12.3 Vaccine Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Aluminum Adjuvant
Table 2. Major Company of Emulsions Adjuvant
Table 3. Major Company of Others
Table 4. Global Vaccine Adjuvants Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Vaccine Adjuvants Sales by Type (2018-2024) & (MT)
Table 6. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Vaccine Adjuvants Sales by Type (2018-2024) & (US& Million)
Table 8. Global Vaccine Adjuvants Market Share in Value by Type (2018-2024)
Table 9. Global Vaccine Adjuvants Price by Type (2018-2024) & (USD/Kg)
Table 10. Global Vaccine Adjuvants Sales by Type (2024-2034) & (MT)
Table 11. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Vaccine Adjuvants Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Vaccine Adjuvants Sales Market Share in Value by Type (2024-2034)
Table 14. Global Vaccine Adjuvants Price by Type (2024-2034) & (USD/Kg)
Table 15. North America Vaccine Adjuvants Sales by Type (2018-2024) & (MT)
Table 16. North America Vaccine Adjuvants Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Vaccine Adjuvants Sales (MT) by Type (2018-2024)
Table 18. Europe Vaccine Adjuvants Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Vaccine Adjuvants Sales (MT) by Type (2018-2024)
Table 20. Asia-Pacific Vaccine Adjuvants Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Vaccine Adjuvants Sales (MT) by Type (2018-2024)
Table 22. Latin America Vaccine Adjuvants Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Vaccine Adjuvants Sales (MT) by Type (2018-2024)
Table 24. Middle East and Africa Vaccine Adjuvants Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Vaccine Adjuvants Sales by Company (2018-2024) & (MT)
Table 26. Global Vaccine Adjuvants Sales Share by Company (2018-2024)
Table 27. Global Vaccine Adjuvants Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Vaccine Adjuvants Revenue Share by Company (2018-2024)
Table 29. Global Market Vaccine Adjuvants Price by Company (2018-2024) & (USD/Kg)
Table 30. Global Vaccine Adjuvants Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)
Table 33. Date of Key Manufacturers Enter into Vaccine Adjuvants Market
Table 34. Key Manufacturers Vaccine Adjuvants Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Vaccine Adjuvants Sales by Region (2018-2024) & (MT)
Table 38. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Vaccine Adjuvants Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Vaccine Adjuvants Sales Market Share in Value by Region (2018-2024)
Table 41. Global Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 42. Global Vaccine Adjuvants Sales by Region (2024-2034) & (MT)
Table 43. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Vaccine Adjuvants Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Vaccine Adjuvants Sales Market Share in Value by Region (2024-2034)
Table 46. Global Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 47. Global Vaccine Adjuvants Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Vaccine Adjuvants Sales by Application (2018-2024) & (MT)
Table 49. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Vaccine Adjuvants Sales Market Share in Value by Application (2018-2024)
Table 52. Global Vaccine Adjuvants Price by Application (2018-2024) & (USD/Kg)
Table 53. Global Vaccine Adjuvants Sales by Application (2024-2034) & (MT)
Table 54. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Vaccine Adjuvants Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Vaccine Adjuvants Sales Market Share in Value by Application (2024-2034)
Table 57. Global Vaccine Adjuvants Price by Application (2024-2034) & (USD/Kg)
Table 58. North America Vaccine Adjuvants Sales by Application (2018-2024) (MT)
Table 59. North America Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Vaccine Adjuvants Sales by Application (2018-2024) (MT)
Table 61. Europe Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Vaccine Adjuvants Sales by Application (2018-2024) (MT)
Table 63. Asia-Pacific Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Vaccine Adjuvants Sales by Application (2018-2024) (MT)
Table 65. Latin America Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Vaccine Adjuvants Sales by Application (2018-2024) (MT)
Table 67. Middle East and Africa Vaccine Adjuvants Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Vaccine Adjuvants Sales by Country (2018-2024) & (MT)
Table 69. North America Vaccine Adjuvants Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Vaccine Adjuvants Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Vaccine Adjuvants Sales Market Share in Value by Country (2018-2024)
Table 72. North America Vaccine Adjuvants Sales by Country (2024-2034) & (MT)
Table 73. North America Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Vaccine Adjuvants Sales by Country (2018-2024) & (MT)
Table 77. Europe Vaccine Adjuvants Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Vaccine Adjuvants Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Vaccine Adjuvants Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Vaccine Adjuvants Sales by Country (2024-2034) & (MT)
Table 81. Europe Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Vaccine Adjuvants Sales by Region (2018-2024) & (MT)
Table 85. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Vaccine Adjuvants Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Vaccine Adjuvants Sales by Region (2024-2034) & (MT)
Table 89. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Vaccine Adjuvants Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Vaccine Adjuvants Sales by Country (2018-2024) & (MT)
Table 93. Latin America Vaccine Adjuvants Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Vaccine Adjuvants Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Vaccine Adjuvants Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Vaccine Adjuvants Sales by Country (2024-2034) & (MT)
Table 97. Latin America Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Vaccine Adjuvants Sales by Country (2018-2024) & (MT)
Table 101. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Vaccine Adjuvants Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Vaccine Adjuvants Sales by Country (2024-2034) & (MT)
Table 105. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Vaccine Adjuvants Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 111. GSK Vaccine Adjuvants Product
Table 112. GSK Recent Development
Table 113. CSL Limited Company Information
Table 114. CSL Limited Introduction and Business Overview
Table 115. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 116. CSL Limited Vaccine Adjuvants Product
Table 117. CSL Limited Recent Development
Table 118. Croda Company Information
Table 119. Croda Introduction and Business Overview
Table 120. Croda Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 121. Croda Vaccine Adjuvants Product
Table 122. Croda Recent Development
Table 123. SEPPIC Company Information
Table 124. SEPPIC Introduction and Business Overview
Table 125. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 126. SEPPIC Vaccine Adjuvants Product
Table 127. SEPPIC Recent Development
Table 128. Novavax Company Information
Table 129. Novavax Introduction and Business Overview
Table 130. Novavax Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 131. Novavax Vaccine Adjuvants Product
Table 132. Novavax Recent Development
Table 133. SPI Pharma Company Information
Table 134. SPI Pharma Introduction and Business Overview
Table 135. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 136. SPI Pharma Vaccine Adjuvants Product
Table 137. SPI Pharma Recent Development
Table 138. Phibro Company Information
Table 139. Phibro Introduction and Business Overview
Table 140. Phibro Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 141. Phibro Vaccine Adjuvants Product
Table 142. Phibro Recent Development
Table 143. SDA BIO Company Information
Table 144. SDA BIO Introduction and Business Overview
Table 145. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 146. SDA BIO Vaccine Adjuvants Product
Table 147. SDA BIO Recent Development
Table 148. Invivogen Company Information
Table 149. Invivogen Introduction and Business Overview
Table 150. Invivogen Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 151. Invivogen Vaccine Adjuvants Product
Table 152. Invivogen Recent Development
Table 153. Tj Kaiwei Company Information
Table 154. Tj Kaiwei Introduction and Business Overview
Table 155. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 156. Tj Kaiwei Vaccine Adjuvants Product
Table 157. Tj Kaiwei Recent Development
Table 158. OZ Biosciences Company Information
Table 159. OZ Biosciences Introduction and Business Overview
Table 160. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 161. OZ Biosciences Vaccine Adjuvants Product
Table 162. OZ Biosciences Recent Development
Table 163. Brenntag Biosector Company Information
Table 164. Brenntag Biosector Introduction and Business Overview
Table 165. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 166. Brenntag Biosector Vaccine Adjuvants Product
Table 167. Brenntag Biosector Recent Development
Table 168. MVP Laboratories Company Information
Table 169. MVP Laboratories Introduction and Business Overview
Table 170. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 171. MVP Laboratories Vaccine Adjuvants Product
Table 172. MVP Laboratories Recent Development
Table 173. Zhuoyue Company Information
Table 174. Zhuoyue Introduction and Business Overview
Table 175. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 176. Zhuoyue Vaccine Adjuvants Product
Table 177. Zhuoyue Recent Development
Table 178. Aphios Company Information
Table 179. Aphios Introduction and Business Overview
Table 180. Aphios Vaccine Adjuvants Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 181. Aphios Vaccine Adjuvants Product
Table 182. Aphios Recent Development
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Vaccine Adjuvants Market Trends
Table 186. Vaccine Adjuvants Market Drivers
Table 187. Vaccine Adjuvants Market Challenges
Table 188. Vaccine Adjuvants Market Restraints
Table 189. Vaccine Adjuvants Distributors List
Table 190. Vaccine Adjuvants Downstream Customers
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vaccine Adjuvants Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Vaccine Adjuvants Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Aluminum Adjuvant
Figure 6. Global Aluminum Adjuvant Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Emulsions Adjuvant
Figure 8. Global Emulsions Adjuvant Sales YoY Growth (2018-2034) & (MT)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (MT)
Figure 11. Global Vaccine Adjuvants Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Vaccine Adjuvants Sales Market Share by Type in 2022 & 2034
Figure 13. North America Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 14. North America Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 15. Europe Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 16. Europe Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 19. Latin America Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine Adjuvants Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine Adjuvants Revenue in 2022
Figure 25. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Human Vaccine
Figure 27. Global Human Vaccine Sales YoY Growth (2018-2034) & (MT)
Figure 28. Product Picture of Veterinary Vaccine
Figure 29. Global Veterinary Vaccine Sales YoY Growth (2018-2034) & (MT)
Figure 30. Global Vaccine Adjuvants Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Vaccine Adjuvants Sales Market Share by Application in 2022 & 2034
Figure 32. North America Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 33. North America Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 34. Europe Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 35. Europe Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 38. Latin America Vaccine Adjuvants Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Vaccine Adjuvants Manufacturing Cost Structure
Figure 43. Vaccine Adjuvants Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries